This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Institute for Basic Science, Korea Advanced Institute of Science and Technology. Active years: 2026.
Company Filing History:
1 out of 99 
1 out of 2,781 
Years Active: 2026
Title: The Innovations of Hangyeol Choi
Introduction
Hangyeol Choi is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioconjugation through his innovative research and patents. His work focuses on developing compounds that have practical applications in various scientific domains.
Latest Patents
One of Hangyeol Choi's key patents is titled "Quinolinone derivative compound selectively binding to cysteine, peptide conjugate thereof, and antibody-drug conjugate comprising same." This patent describes a quinolinone derivative compound that selectively binds to cysteine, an amino acid, along with its peptide conjugate and an antibody-drug conjugate. The innovative aspect of this patent lies in the formation of a conjugate with high chemoselectivity and yield through a radical pathway induced by visible light. This advancement opens up numerous possibilities for applications in bioconjugation.
Career Highlights
Throughout his career, Hangyeol Choi has worked with prestigious institutions such as the Institute for Basic Science and the Korea Advanced Institute of Science and Technology. His research has contributed to the advancement of scientific knowledge and practical applications in his field.
Collaborations
Hangyeol Choi has collaborated with several talented individuals, including Sungwoo Hong and Jaebong Jang. These collaborations have further enriched his research and innovation efforts.
Conclusion
Hangyeol Choi's contributions to the field of bioconjugation through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the scientific community and pave the way for future advancements.